These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 34742927)

  • 1. A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine.
    Abobaker A; Idris MA; Ogunjimi O
    Int J Infect Dis; 2022 Jan; 114():29-30. PubMed ID: 34742927
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech).
    Kim MJ; Kim JW; Kim MS; Choi SY; Na JI
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e98-e100. PubMed ID: 34661942
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine.
    Ackerman M; Henry D; Finon A; Binois R; Esteve E
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e423-e425. PubMed ID: 33783017
    [No Abstract]   [Full Text] [Related]  

  • 4. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine.
    Vassallo C; Boveri E; Brazzelli V; Rampino T; Bruno R; Bonometti A; Gregorini M
    Dermatol Ther; 2021 Sep; 34(5):e15076. PubMed ID: 34327795
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 vaccine-induced urticarial vasculitis.
    Dash S; Behera B; Sethy M; Mishra J; Garg S
    Dermatol Ther; 2021 Sep; 34(5):e15093. PubMed ID: 34369046
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukocytoclastic Vasculitic Rash Following Second Dose of Moderna COVID-19 Vaccine.
    Ireifej B; Weingarten M; Dhamrah U; Weingarten M; Hadi S
    J Investig Med High Impact Case Rep; 2022; 10():23247096211066283. PubMed ID: 35293793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema migrans-like rash after Moderna vaccine: An uncommon type of "COVID arm".
    Zengarini C; Artanidi C; Preci C; Gaspari V
    Dermatol Ther; 2021 Sep; 34(5):e15063. PubMed ID: 34250736
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin rashes after SARS-CoV-2 vaccine: which relationship, if any?
    Patruno C; Napolitano M; Stingeni L; Fabbrocini G
    Immun Inflamm Dis; 2021 Sep; 9(3):622-623. PubMed ID: 34145775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash.
    Stoyanov A; Thompson G; Lee M; Katelaris C
    Ann Allergy Asthma Immunol; 2022 Mar; 128(3):321-322. PubMed ID: 34813953
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis.
    Bostan E; Zaid F; Akdogan N; Gokoz O
    J Cosmet Dermatol; 2022 Jan; 21(1):51-53. PubMed ID: 34705320
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous small-vessel vasculitis following COVID-19 vaccine.
    Kar BR; Singh BS; Mohapatra L; Agrawal I
    J Cosmet Dermatol; 2021 Nov; 20(11):3382-3383. PubMed ID: 34529877
    [No Abstract]   [Full Text] [Related]  

  • 13. Eruptive angiomatosis after SARS-CoV-2 vaccine (Comirnaty, Pfizer).
    Zengarini C; Misciali C; Lazzarotto T; Dika E
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e90-e91. PubMed ID: 34606666
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine.
    Gillion V; Jadoul M; Demoulin N; Aydin S; Devresse A
    Kidney Int; 2021 Sep; 100(3):706-707. PubMed ID: 34237323
    [No Abstract]   [Full Text] [Related]  

  • 15. Localized cutaneous reaction to an mRNA COVID-19 vaccine.
    Edriss M; Farshchian M; Daveluy S
    J Cosmet Dermatol; 2021 Aug; 20(8):2380-2381. PubMed ID: 34129749
    [No Abstract]   [Full Text] [Related]  

  • 16. Widespread cutaneous small vessel vasculitis secondary to COVID-19 infection.
    Tahir A; Sohail Z; Nasim B; Parmar NV
    Int J Dermatol; 2020 Oct; 59(10):1278-1279. PubMed ID: 32880974
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?
    Izzedine H; Bonilla M; Jhaveri KD
    Nephrol Dial Transplant; 2021 Aug; 36(9):1565-1569. PubMed ID: 34245294
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactivation of IgA vasculitis following COVID-19 vaccination.
    Maye JA; Chong HP; Rajagopal V; Petchey W
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.
    Wheeler SE; Shurin GV; Yost M; Anderson A; Pinto L; Wells A; Shurin MR
    Microbiol Spectr; 2021 Sep; 9(1):e0034121. PubMed ID: 34346750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.